370 related articles for article (PubMed ID: 15572177)
1. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
[TBL] [Abstract][Full Text] [Related]
2. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.
Inestrosa NC; Godoy JA; Quintanilla RA; Koenig CS; Bronfman M
Exp Cell Res; 2005 Mar; 304(1):91-104. PubMed ID: 15707577
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA; van Tijn P; Zivkovic D
Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
[TBL] [Abstract][Full Text] [Related]
5. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC
J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354
[TBL] [Abstract][Full Text] [Related]
6. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Toledo EM; Inestrosa NC
Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
[TBL] [Abstract][Full Text] [Related]
7. Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers.
Chacón MA; Varela-Nallar L; Inestrosa NC
J Cell Physiol; 2008 Oct; 217(1):215-27. PubMed ID: 18521822
[TBL] [Abstract][Full Text] [Related]
8. Cellular localization and signaling activity of beta-catenin in migrating neural crest cells.
de Melker AA; Desban N; Duband JL
Dev Dyn; 2004 Aug; 230(4):708-26. PubMed ID: 15254905
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor.
Lee EO; Shin YJ; Chong YH
J Neuroimmunol; 2004 Oct; 155(1-2):21-31. PubMed ID: 15342193
[TBL] [Abstract][Full Text] [Related]
10. The role of Wnt signaling in neuroprotection.
Cerpa W; Toledo EM; Varela-Nallar L; Inestrosa NC
Drug News Perspect; 2009 Dec; 22(10):579-91. PubMed ID: 20140278
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling through canonical and non-canonical pathways: recent progress.
Widelitz R
Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
13. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid oligomers affect the structure and function of the postsynaptic region: role of the Wnt signaling pathway.
Dinamarca MC; Colombres M; Cerpa W; Bonansco C; Inestrosa NC
Neurodegener Dis; 2008; 5(3-4):149-52. PubMed ID: 18322375
[TBL] [Abstract][Full Text] [Related]
15. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
Salins P; Shawesh S; He Y; Dibrov A; Kashour T; Arthur G; Amara F
Neurosci Lett; 2007 Feb; 412(3):211-6. PubMed ID: 17234346
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.
Yamin G
J Neurosci Res; 2009 Jun; 87(8):1729-36. PubMed ID: 19170166
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
Simon M; Grandage VL; Linch DC; Khwaja A
Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling function in Alzheimer's disease.
De Ferrari GV; Inestrosa NC
Brain Res Brain Res Rev; 2000 Aug; 33(1):1-12. PubMed ID: 10967351
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression.
Wang PY; Chen JJ; Su HM
J Nutr Biochem; 2010 Apr; 21(4):345-50. PubMed ID: 19423322
[TBL] [Abstract][Full Text] [Related]
20. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
